Latest Breaking News On - Recurrent ovarian cancer - Page 1 : comparemela.com

AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024

AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSusan galbraithDave fredricksonDaiichi sankyo incDaiichi sankyo companyMerck co incAbelzeta pharmaceuticals incAmerican society of clinical oncologyAmerican societyClinical oncologyAnnual meetingRapid oral abstractExecutive vice presidentOncology business unitAbelzeta pharmaceuticals

Early Data for CRX100 Pave Way for Potential Combinations in Recurrent, Platinum-Resistant Ovarian Cancer

Oliver Dorigo, MD, PhD, discusses the investigation of CRX100 in patients with recurrent, platinum-resistant ovarian cancer.

United statesOliver dorigoMary lake polan gynecologic oncology research laboratoryDivision of gynecologic oncologyStanford gynecologic oncology clinical care programStanford gynecologic oncology fellowshipStanford clinical research groupGynecologic cancer trialsStanford obstetricsGynecologic oncologyRecurrent ovarian cancerGo annual meeting on womens cancerPlatinum resistant

AIM ImmunoTech Inc : AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

AIM ImmunoTech Inc : AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Dennis riedlChristopher mcaleerThomask equelsAstrazeneca imfinziEarly access programClinical cancer researchExchange commissionErasmus medical centerImmunotech incExecutive officer thomasClinical cancerRecurrent ovarian cancerAdvanced pancreatic adenocarcinomaFinancial highlightsFiscal yearChief executive officer

AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Year marked by growing body of promising data demonstrating Ampligen’s potential to address multiple high-value indications Company to host conference call and webcast today, April 2nd at 8:30.

United statesThomask equelsChristopher mcaleerAstrazeneca imfinziEarly access programExchange commissionClinical cancer researchImmunotech incErasmus medical centerExecutive officer thomasClinical cancerRecurrent ovarian cancerAdvanced pancreatic adenocarcinomaFinancial highlightsFiscal yearChief executive officer

AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update

AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesThomask equelsExchange commissionOngoing business developmentImmunotech incExecutive officer thomasRecurrent ovarian cancerAdvanced pancreatic adenocarcinomaPrivate securities litigation reform act